KLH.V Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-0.0649|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-4.808M|
|Gross Profit Margin (Quarterly)||16.72%|
|Profit Margin (Quarterly)||-631.7%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM)||Upgrade|
KLH.V Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Stellar Biotechnologies is down 35.84% over the last year vs and S&P 500 Total Return up 13.92%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for KLH.V
Portfolio Strategies Featuring KLH.V
Did Stellar Biotechnologies make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.stellarbiotechnologies.com
- IR Website: http://ir.stellarbiotechnologies.com/
- HQ Country: United States
- HQ State/Province: California
- Incorporation Country: Canada
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: May 31, 2015
- Est. Current Fiscal Year End: August 31, 2015
- Last Fiscal Quarter End: December 31, 2014
- Last Fiscal Year End: September 30, 2014
- Next Earnings Release: N/A
Stellar Biotechnologies Inc is a biotechnology company engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH) protein.
KLH.V Excel Add-In Codes
- Name: =YCI("KLH.V","name")
- Description: =YCI("KLH.V","description")
- Sector: =YCI("KLH.V","sector")
- Industry: =YCI("KLH.V","industry")
- Est. Current Fiscal Year End: =YCI("KLH.V","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.